Pain, swelling, and inflammation are common symptoms that can occur after a non-surgical post-traumatic event or blunt trauma. These symptoms are a natural part of the body’s healing process and are typically seen within the first 24 hours after the injury. During this initial stage of inflammation, it is important to manage these symptoms to promote healing and provide relief to the patient.

Post-traumatic swelling and inflammation are common symptoms following injuries or trauma. Several topical formulations of diclofenac have been studied for their effectiveness in treating these symptoms. These formulations include solutions, emulsion gels, controlled-release pellets, and polymeric film coatings. These formulations have shown promising results in controlled drug release, providing sustained relief from swelling and inflammation. The effectiveness of topical formulations of diclofenac in treating post-traumatic swelling and inflammation in humans has been studied. Based on the available research, topical formulations of diclofenac have shown to be effective in reducing post-traumatic swelling and inflammation in humans. Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution or as an emulsion gel. Additionally, comparative studies have shown that topical diclofenac has a similar short-term effect in reducing pain and improving function compared to oral forms of the drug for symptoms of osteoarthritis in a single knee.

Non-surgical trauma, such as sprains, strains, and bruises, often results in pain, swelling, and inflammation. Dynapar QPS is a novel topical formulation of diclofenac diethylamine, a nonsteroidal anti-inflammatory drug that can be applied directly to the affected area. It works by inhibiting the production of prostaglandins, which are responsible for inflammation and pain. Using topical diclofenac in non-surgical trauma can help alleviate pain, reduce swelling, and decrease inflammation, providing localized relief without the need for oral medications or invasive procedures. Dynapar QPS that can be applied directly to the affected area and is known to have analgesic and anti-inflammatory properties. It is also well-tolerated and safe for topical use, with minimal risk of systemic side effects. Additionally, topical diclofenac has been extensively studied and proven to be effective in managing various types of acute and chronic pain, including musculoskeletal pain, joint pain, and soft tissue injuries. Overall, topical diclofenac is a safe and effective option for managing pain, swelling, and inflammation in non-surgical trauma cases. Using topical diclofenac in non-surgical trauma can provide targeted relief of pain, swelling, and inflammation without the need for oral medications or invasive procedures. It is a convenient and practical option for patients who prefer topical treatments or those who may have contraindications to systemic medications. Additionally, topical diclofenac has been shown to have a faster onset of action compared to oral medications, providing quicker relief to patients.

This study has been designed to observe the effectiveness of Dynapar QPS over the marketed product of Diclofenac Diethylamine 1.16% w/w Topical Gel in the treatment of post traumatic swelling / inflammation